Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Almorexant for Treatment of Primary Insomnia

Drug (Brand/Generic)

Almorexant

Company/Licensee

Actelion/GSK

Therapy Class

Orexin receptor antagonist

Product Description

Transient and reversible blockade of the orexin receptors

Current Indication

Treatment of insomnia

Market Sector

CNS

Development Status

Discontinued
Expand
Close
Close
Close

Go Top